Paul Jasper

996 total citations
22 papers, 732 citations indexed

About

Paul Jasper is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Paul Jasper has authored 22 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Paul Jasper's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Protein purification and stability (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Paul Jasper is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Protein purification and stability (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Paul Jasper collaborates with scholars based in United States, United Kingdom and Japan. Paul Jasper's co-authors include Peter K. Sorger, Douglas A. Lauffenburger, Birgit Schoeberl, Ulrik B. Nielsen, Mario Niepel, William W. Chen, Katherine L. Knight, John Tolsma, Susan L. Kalis and Periannan Sethupathi and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer Research.

In The Last Decade

Paul Jasper

20 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Jasper United States	13	459	161	133	116	93	22	732
Ben‐Fillippo Krippendorff Switzerland	11	439 1.0×	189 1.2×	257 1.9×	124 1.1×	58 0.6×	17	763
Clarissa G. Jakob United States	17	594 1.3×	158 1.0×	139 1.0×	93 0.8×	91 1.0×	23	1.0k
Qiaodan Zhou China	10	535 1.2×	132 0.8×	73 0.5×	62 0.5×	105 1.1×	21	815
Yibei Xiao China	16	377 0.8×	250 1.6×	49 0.4×	134 1.2×	70 0.8×	60	766
Eric Vangrevelinghe Switzerland	16	349 0.8×	171 1.1×	37 0.3×	84 0.7×	175 1.9×	27	859
O. Joseph Trask United States	17	336 0.7×	112 0.7×	28 0.2×	98 0.8×	64 0.7×	29	704
Joseph Marakovits United States	10	657 1.4×	349 2.2×	36 0.3×	145 1.3×	99 1.1×	12	1.0k
Murray McKinnon United States	17	469 1.0×	117 0.7×	85 0.6×	284 2.4×	53 0.6×	35	902
Christopher J. Giuliano United States	8	662 1.4×	144 0.9×	37 0.3×	73 0.6×	82 0.9×	12	920
Sulin Zhang China	16	465 1.0×	139 0.9×	31 0.2×	115 1.0×	176 1.9×	46	725

Countries citing papers authored by Paul Jasper

Since Specialization

Citations

This map shows the geographic impact of Paul Jasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jasper more than expected).

Fields of papers citing papers by Paul Jasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Jasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jasper. The network helps show where Paul Jasper may publish in the future.

Co-authorship network of co-authors of Paul Jasper

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Jasper. A scholar is included among the top collaborators of Paul Jasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Jasper. Paul Jasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nguyen, Hoa Q., et al.. (2024). A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 721–734.

Betts, Alison, Tracey Clark, Paul Jasper, et al.. (2020). Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1. Journal of Pharmacokinetics and Pharmacodynamics. 47(5). 513–526. 19 indexed citations

Jones, Hannah M., John Tolsma, Zhiwei Zhang, et al.. (2020). A Physiologically‐Based Pharmacokinetic Model for the Prediction of “Half‐Life Extension” and “Catch and Release” Monoclonal Antibody Pharmacokinetics. CPT Pharmacometrics & Systems Pharmacology. 9(9). 534–541. 12 indexed citations

Kaddi, Chanchala, John Tolsma, Paul Jasper, et al.. (2020). A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat. CPT Pharmacometrics & Systems Pharmacology. 9(7). 374–383. 20 indexed citations

Jones, Hannah M., Zhiwei Zhang, Paul Jasper, et al.. (2019). A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics FromIn VitroData. CPT Pharmacometrics & Systems Pharmacology. 8(10). 738–747. 35 indexed citations

Kaddi, Chanchala, Rena Baek, Paul Jasper, et al.. (2018). Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology and Pharmacology. CPT Pharmacometrics & Systems Pharmacology. 7(7). 442–452. 29 indexed citations

Kaddi, Chanchala, Rena Baek, Paul Jasper, et al.. (2017). Quantitative systems pharmacology model of acid sphingomyelinase deficiency and the enzyme replacement therapy olipudase alfa is aninnovative tool for linking pathophysiology and pharmacology. Molecular Genetics and Metabolism. 120(1-2). S72–S73. 1 indexed citations

Shankaran, Harish, Anna Cronin, Jen Barnes, et al.. (2017). Systems Pharmacology Model of Gastrointestinal Damage Predicts Species Differences and Optimizes Clinical Dosing Schedules. CPT Pharmacometrics & Systems Pharmacology. 7(1). 26–33. 14 indexed citations

Betts, Alison, Nahor Haddish‐Berhane, John Tolsma, et al.. (2016). Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin. The AAPS Journal. 18(5). 1101–1116. 48 indexed citations

10.

Tiwari, Abhinav, et al.. (2016). Assessing the Impact of Tissue Target Concentration Data on Uncertainty in In Vivo Target Coverage Predictions. CPT Pharmacometrics & Systems Pharmacology. 5(10). 565–574. 7 indexed citations

11.

Yates, James, et al.. (2015). Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738. Scientific Reports. 5(1). 13545–13545. 42 indexed citations

12.

Chien, Hung‐Chun, Tristan S. Maurer, Sook Wah Yee, et al.. (2015). Rapid Method To Determine Intracellular Drug Concentrations in Cellular Uptake Assays: Application to Metformin in Organic Cation Transporter 1–Transfected Human Embryonic Kidney 293 Cells. Drug Metabolism and Disposition. 44(3). 356–364. 53 indexed citations

13.

Chabot, J, et al.. (2011). Comprehensive mechanism-based antibody pharmacokinetic modeling. PubMed. 35. 4318–4323. 10 indexed citations

14.

Lazzara, Matthew J., Keara Lane, Richard Chan, et al.. (2010). Impaired SHP2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Growth Factor Receptor–Activating Mutations. Cancer Research. 70(9). 3843–3850. 49 indexed citations

15.

Chen, William W., Birgit Schoeberl, Paul Jasper, et al.. (2009). Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Molecular Systems Biology. 5(1). 239–239. 276 indexed citations

16.

Jasper, Paul, et al.. (2007). B lymphocyte deficiency in IgH‐transgenic rabbits. European Journal of Immunology. 37(8). 2290–2299. 8 indexed citations

17.

Rhee, Ki‐Jong, et al.. (2004). Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues. The Journal of Experimental Medicine. 201(1). 55–62. 51 indexed citations

18.

Jasper, Paul, Shi-Kang Zhai, Susan L. Kalis, M Kingzette, & Katherine L. Knight. (2003). B Lymphocyte Development in Rabbit: Progenitor B Cells and Waning of B Lymphopoiesis. The Journal of Immunology. 171(12). 6372–6380. 47 indexed citations

19.

Lanning, Dennis, Paul Jasper, & Katherine L. Knight. (2002). IgH haplotype exclusion in rabbits. Seminars in Immunology. 14(3). 163–168. 3 indexed citations

20.

Lanning, Dennis, Paul Jasper, & Katherine L. Knight. (2002). Seminars in Immunology comments. Seminars in Immunology. 14(3). 229–229.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact